Cellectar Biosciences PE Ratio 2010-2025 | CLRB
Current and historical p/e ratio for Cellectar Biosciences (CLRB) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Cellectar Biosciences PE ratio as of June 27, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Cellectar Biosciences PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-06-27 | 7.90 | 0.00 | |
| 2025-03-31 | 9.46 | $-0.73 | 0.00 |
| 2024-12-31 | 8.97 | $-1.33 | 0.00 |
| 2024-09-30 | 64.20 | $-1.72 | 0.00 |
| 2024-06-30 | 75.00 | $-2.53 | 0.00 |
| 2024-03-31 | 119.40 | $-3.08 | 0.00 |
| 2023-12-31 | 83.10 | $-3.10 | 0.00 |
| 2023-09-30 | 79.20 | $-3.25 | 0.00 |
| 2023-06-30 | 58.50 | $-3.32 | 0.00 |
| 2023-03-31 | 42.90 | $-3.81 | 0.00 |
| 2022-12-31 | 51.30 | $-4.05 | 0.00 |
| 2022-09-30 | 100.80 | $-4.50 | 0.00 |
| 2022-06-30 | 121.14 | $-4.22 | 0.00 |
| 2022-03-31 | 206.34 | $-4.10 | 0.00 |
| 2021-12-31 | 199.20 | $-4.40 | 0.00 |
| 2021-09-30 | 277.50 | $-4.10 | 0.00 |
| 2021-06-30 | 357.00 | $-4.60 | 0.00 |
| 2021-03-31 | 483.00 | $-6.10 | 0.00 |
| 2020-12-31 | 624.00 | $-9.00 | 0.00 |
| 2020-09-30 | 372.00 | $-11.60 | 0.00 |
| 2020-06-30 | 384.00 | $-14.30 | 0.00 |
| 2020-03-31 | 399.93 | $-16.30 | 0.00 |
| 2019-12-31 | 675.00 | $-19.70 | 0.00 |
| 2019-09-30 | 600.00 | $-16.40 | 0.00 |
| 2019-06-30 | 654.00 | $-28.70 | 0.00 |
| 2019-03-31 | 705.00 | $-41.00 | 0.00 |
| 2018-12-31 | 465.00 | $-54.40 | 0.00 |
| 2018-09-30 | 900.00 | $-3,454.40 | 0.00 |
| 2018-06-30 | 1860.00 | $-3,463.90 | 0.00 |
| 2018-03-31 | 3405.00 | $-3,470.00 | 0.00 |
| 2017-12-31 | 4110.00 | $-3,473.00 | 0.00 |
| 2017-09-30 | 5010.00 | $-107.00 | 0.00 |
| 2017-06-30 | 4890.00 | $-124.00 | 0.00 |
| 2017-03-31 | 6810.00 | $-150.00 | 0.00 |
| 2016-12-31 | 3660.00 | $-35.00 | 0.00 |
| 2016-09-30 | 8130.00 | $-1.00 | 0.00 |
| 2016-06-30 | 10320.00 | $-208.00 | 0.00 |
| 2016-03-31 | 10254.90 | $-459.00 | 0.00 |
| 2015-12-31 | 22050.00 | $-850.00 | 0.00 |
| 2015-09-30 | 59100.00 | $-1,070.00 | 0.00 |
| 2015-06-30 | 86400.00 | $-920.00 | 0.00 |
| 2015-03-31 | 93300.00 | $-1,350.00 | 0.00 |
| 2014-12-31 | 92700.00 | $-2,050.00 | 0.00 |
| 2014-09-30 | 66600.00 | $-3,230.00 | 0.00 |
| 2014-06-30 | 191700.00 | $-6,130.00 | 0.00 |
| 2014-03-31 | 234000.00 | $-6,200.00 | 0.00 |
| 2013-12-31 | 222000.00 | $-6,600.00 | 0.00 |
| 2013-09-30 | 216000.00 | $-6,200.00 | 0.00 |
| 2013-06-30 | 276000.00 | $-4,400.00 | 0.00 |
| 2013-03-31 | 276300.00 | $-4,800.00 | 0.00 |
| 2012-12-31 | 444000.00 | $-4,600.00 | 0.00 |
| 2012-09-30 | 630000.00 | $-4,800.00 | 0.00 |
| 2012-06-30 | 714000.00 | $-5,000.00 | 0.00 |
| 2012-03-31 | 510000.00 | $-5,800.00 | 0.00 |
| 2011-12-31 | 264000.00 | $-11,400.00 | 0.00 |
| 2011-09-30 | 762000.00 | $-11,800.00 | 0.00 |
| 2011-06-30 | 780000.00 | $-10,800.00 | 0.00 |
| 2011-03-31 | 1000000.00 | $-70,338.45 | 0.00 |
| 2010-12-31 | 1000000.00 | $-2,000.00 | 0.00 |
| 2010-09-30 | 1000000.00 | $-800,399.90 | 0.00 |
| 2010-06-30 | 1000000.00 | $-1,015,384.50 | 0.00 |
| 2010-03-31 | 1000000.00 | $-1,353,846.05 | 0.00 |
| 2009-12-31 | 1000000.00 | $-1,630,769.10 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.013B | $0.000B |
| Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.564B | 27.96 |
| Boston Scientific (BSX) | United States | $154.721B | 38.73 |
| Stryker (SYK) | United States | $149.011B | 31.16 |
| EssilorLuxottica (ESLOY) | France | $125.383B | 0.00 |
| Medtronic (MDT) | Ireland | $110.530B | 15.67 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.919B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.856B | 26.72 |
| ResMed (RMD) | United States | $37.567B | 28.22 |
| GE HealthCare Technologies (GEHC) | United States | $34.277B | 16.27 |
| Agilent Technologies (A) | United States | $33.923B | 22.11 |
| Terumo (TRUMY) | Japan | $27.568B | 35.81 |
| Koninklijke Philips (PHG) | Netherlands | $23.187B | 16.27 |
| Insulet (PODD) | United States | $21.804B | 85.59 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.151B | 11.66 |
| Baxter (BAX) | United States | $15.652B | 11.69 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.231B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.625B | 23.06 |
| Lantheus Holdings (LNTH) | United States | $5.586B | 14.09 |
| Prestige Consumer Healthcare (PBH) | United States | $4.010B | 17.91 |
| Perrigo (PRGO) | Ireland | $3.653B | 9.26 |
| Haemonetics (HAE) | United States | $3.592B | 16.36 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.330B | 27.68 |
| ICU Medical (ICUI) | United States | $3.216B | 23.72 |
| GN Store Nord (GNNDY) | Denmark | $2.307B | 19.11 |
| QuidelOrtho (QDEL) | United States | $1.941B | 13.35 |
| LeMaitre Vascular (LMAT) | United States | $1.862B | 41.62 |
| AtriCure (ATRC) | United States | $1.628B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.271B | 12.90 |
| Acuren (TIC) | United States | $1.252B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.120B | 25.19 |
| Neogen (NEOG) | United States | $1.040B | 13.31 |
| BioLife Solutions (BLFS) | United States | $1.020B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.018B | 13.02 |
| Kestra Medical Technologies (KMTS) | United States | $0.919B | 0.00 |
| InMode (INMD) | Israel | $0.889B | 8.96 |
| CeriBell (CBLL) | United States | $0.697B | 0.00 |
| Owens & Minor (OMI) | United States | $0.644B | 5.34 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.606B | 0.00 |
| Evolus (EOLS) | United States | $0.600B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.551B | 0.00 |
| Valneva SE (VALN) | France | $0.489B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.465B | 0.00 |
| Surmodics (SRDX) | United States | $0.416B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.415B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.352B | 12.94 |
| SNDL (SNDL) | Canada | $0.328B | 0.00 |
| Quanterix (QTRX) | United States | $0.328B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.283B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 23.03 |
| Cerus (CERS) | United States | $0.260B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.252B | 0.00 |
| ZimVie (ZIMV) | United States | $0.251B | 11.39 |
| Cresco Labs (CRLBF) | United States | $0.250B | 0.00 |
| Brainsway (BWAY) | Israel | $0.248B | 65.50 |
| Aurora Cannabis (ACB) | Canada | $0.239B | 71.00 |
| Biote (BTMD) | United States | $0.234B | 6.58 |
| Canopy Growth (CGC) | Canada | $0.228B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.226B | 0.00 |
| Omeros (OMER) | United States | $0.195B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.192B | 0.00 |
| Organigram Global (OGI) | Canada | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 14.93 |
| Verano Holdings (VRNOF) | United States | $0.175B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.136B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 14.79 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Veru (VERU) | United States | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.089B | 11.54 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.083B | 0.00 |
| MacroGenics (MGNX) | United States | $0.080B | 0.00 |
| Zynex (ZYXI) | United States | $0.079B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.079B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| Nephros (NEPH) | United States | $0.045B | 60.57 |
| United-Guardian (UG) | United States | $0.038B | 13.18 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |